Limiting sugar consumption during the first 1,000 days of life, from conception through a child’s second birthday, may be associated with slower biological aging and a reduced risk of cancer up to five decades later. A study published in the Proceedings of the National Academy of Sciences analyzed data from over 64,000 participants in the UK Biobank.
The researchers utilized a natural experiment in post-war Britain, specifically the period following the end of sugar rationing in September 1953. During this time, average daily sugar consumption in the U.K. nearly doubled, from approximately 41 grams to 80 grams, while the intake of other major food groups remained stable. The study compared individuals exposed to sugar rationing during their first 1,000 days with those conceived after rationing ended, examining cancer outcomes recorded about 50 years later.
Results indicated that individuals who experienced more of their early lives under sugar rationing exhibited lower rates of several adult cancers, including liver, rectal, lung, prostate, and breast cancers. These individuals also had longer leukocyte telomeres, protective caps on chromosomes that shorten with age, suggesting approximately two fewer years of biological aging. Furthermore, they showed lower levels of Granzyme B, a protein linked to long-term immune activation and inflammation.
The study authors proposed two potential pathways for these long-term benefits: a biological imprint and a persistent behavioral habit. Five decades after rationing concluded, adults with early-life sugar restrictions continued to consume less sugar and maintained healthier, more varied diets.
Experts noted that the findings contribute to ongoing research on how early diet influences long-term health, although further investigation is needed for confirmation. One of the study's authors highlighted the persistence of these effects, stating that differences in sugar exposure during the first 1,000 days were still reflected in dietary habits and biological markers roughly 50 years later, suggesting early life is crucial for biological development and establishing lasting food preferences.
Medical professionals not involved in the study described it as a valuable hypothesis-generating research. They acknowledged concerns about high sugar intake's link to metabolic disruption, insulin resistance, and chronic inflammation, which may contribute to disease risk. The observed lower cancer rates were considered consistent with the potential role of reduced early sugar exposure and healthier subsequent diets.
However, some oncologists pointed out limitations inherent in studying natural experiments from past decades, citing potential biases in data collection and the low number of cancer cases for some specific types. They also noted that while some findings align with obesity-driven cancers, others, such as reduced lung cancer risk, are traditionally associated with factors like smoking rather than dietary sugar.
The researchers themselves acknowledged that, as a natural experiment rather than a randomized controlled trial, the study could not definitively exclude all other postwar factors. Additionally, the UK Biobank's population may not be fully representative of the broader British public, and it was challenging to isolate the impact of early biological changes versus sustained healthier adult diets.
Study authors cautioned against interpreting the findings as a call for extreme dietary measures, emphasizing instead that the results support existing recommendations to limit added sugar, particularly during pregnancy and early childhood.